Skip to main content
. 2018 May 22;16(1):866–874. doi: 10.3892/ol.2018.8782

Table I.

Clinicopathological characteristics of patients in the TCGA and FUSCC cohorts.

Variables TCGA cohort FUSCC cohort
Total number of patients, n (%) 509 192
Median age (range), years 61 (26–90) 55.5 (17–84)
Sex, n (%)
  Male 328 (64.44) 131 (68.23)
  Female 181 (35.56) 61 (31.77)
Fuhrman grade, n (%)
  1 and 2 234 (45.97) 79 (41.15)
  3 and 4 271 (53.24) 113 (58.85)
  Gx 4 (0.79) 0 (0.00)
Mean longest dimension (range), cm 5.30 (0–20.0) 5.01 (1–16.0)
T, n (%)
  T1 258 (50.69) 129 (67.19)
  T2 63 (12.38) 29 (15.10)
  T3 178 (34.97) 27 (14.06)
  T4 10 (1.96) 7 (3.64)
N, n (%)
  N0 228 (44.79) 181 (94.27)
  N1 18 (3.54) 4 (2.08)
  Nx 263 (51.67) 7 (3.64)
M, n (%)
  M0 406 (79.76) 184 (95.80)
  M1 78 (15.32) 7 (3.60)
  Mx 25 (4.91) 1 (0.50)
Stage, n (%)
  I 253 (49.71) 130 (67.71)
  II 51 (10.02) 30 (15.62)
  III 125 (24.56) 23 (11.98)
  IV 80 (15.72) 9 (4.69)
Laterality, n (%)
  Left 239 (46.95) 90 (46.87)
  Right 269 (52.85) 94 (48.95)
  Bilateral 1 (0.20) 8 (41.67)
Median hemoglobin (range), g/l 139 (76–398)
  Elevated, n (%) 5 (0.98) 20 (10.42)
  Normal, n (%) 175 (34.38) 86 (44.79)
  Low, n (%) 251 (49.31) 16 (8.33)
  Undefined, n (%) 78 (15.32) 70 (36.46)
Median white blood cell count (range), 109/l 6.2 (3.1–18.4)
  Elevated, n (%) 160 (31.43) 3 (1.56)
  Normal, n (%) 251 (49.31) 100 (52.08)
  Low, n (%) 8 (1.57) 17 (8.85)
  Undefined, n (%) 89 (17.49) 72 (37.5)
Median platelet level (range), 109/l 219 (97–450)
  Elevated, n (%) 35 (6.88) 4 (2.08)
  Normal, n (%) 342 (67.19) 103 (53.65)
  Low, n (%) 45 (8.84) 2 (1.04)
  Undefined, n (%) 86 (16.90) 83 (43.23)
Median follow-up time (range), days 1,063 (2–3,668) 1,412 (117–2,245)
Median serum LDH level (range), U/la 155 (67–761)
a

No data present in the TCGA database. TCGA, The Cancer Genome Atlas; FUSCC, Fudan University Shanghai Cancer Centre; Gx, grade cannot be assessed; T, tumour; N, node; M, metastasis; LDH, lactate dehydrogenase.